Videos de Experimentos Relacionados

Evaluación de los nebulizadores de chorro.

M M Clay

Lancet (London, England)

|December 3, 1983

Resumen

No abstract available in PubMed .

Videos de Conceptos Relacionados

También podría leer

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Time engaged in reading. A critical factor in reading achievement.

American annals of the deaf·1992

Same author

Output characteristics of DeVilbiss No. 40 hand-held jet nebulizers.

The European respiratory journal·1990

Same author

Effect of terbutaline administered from metered dose inhaler (2 mg) and subcutaneously (0.25 mg) on tracheobronchial clearance in mild asthma.

British journal of diseases of the chest·1987

Same author

Effect of nebulised aerosol size on lung deposition in patients with mild asthma.

Thorax·1987

Same author

Wastage of drug from nebulisers: a review.

Journal of the Royal Society of Medicine·1987

Same author

Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects.

Thorax·1986

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Ver todos los artículos relacionados

Videos de Experimentos Relacionados

Evaluación de los nebulizadores de chorro.

Videos de Conceptos Relacionados

Artículos Relacionados

Time engaged in reading. A critical factor in reading achievement.

Output characteristics of DeVilbiss No. 40 hand-held jet nebulizers.

Effect of terbutaline administered from metered dose inhaler (2 mg) and subcutaneously (0.25 mg) on tracheobronchial clearance in mild asthma.

Effect of nebulised aerosol size on lung deposition in patients with mild asthma.

Wastage of drug from nebulisers: a review.

Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Videos de Experimentos Relacionados

Evaluación de los nebulizadores de chorro.

Videos de Conceptos Relacionados

Artículos Relacionados

Time engaged in reading. A critical factor in reading achievement.

Output characteristics of DeVilbiss No. 40 hand-held jet nebulizers.

Effect of terbutaline administered from metered dose inhaler (2 mg) and subcutaneously (0.25 mg) on tracheobronchial clearance in mild asthma.

Effect of nebulised aerosol size on lung deposition in patients with mild asthma.

Wastage of drug from nebulisers: a review.

Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.